Fermentalg launches a capital increase to accelerate its development

Fermentalg has announced a capital increase of approximately €10 million to support its commercial development. This transaction includes offerings reserved for qualified investors and a special category of beneficiaries, with a price set at €0.46 per share, representing a 20% discount.

The offering is scheduled to close on May 13, 2026. Subscription commitments totaling approximately €9 million have been secured from Vatel Capital and Huvepharma. The latter investor, also a major shareholder in Fermentalg, has committed to contributing €2 million.

The capital increase will be used to intensify commercial activities, maintain innovation, and support the company's international expansion. The objective is to achieve annual sales of €20 million, particularly through new product lines such as ΩRIGINSTM algal oil and Galdieria BlueTM colorant.